PLpro inhibitor
CAS No. 1093070-14-4
PLpro inhibitor ( —— )
Catalog No. M22162 CAS No. 1093070-14-4
PLpro inhibitor is a potent papain-like protease (PLpro) inhibitor(IC50 of 2.6 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 174 | In Stock |
|
5MG | 260 | In Stock |
|
10MG | 372 | In Stock |
|
25MG | 619 | In Stock |
|
50MG | 881 | In Stock |
|
100MG | 1188 | In Stock |
|
500MG | 2367 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePLpro inhibitor
-
NoteResearch use only, not for human use.
-
Brief DescriptionPLpro inhibitor is a potent papain-like protease (PLpro) inhibitor(IC50 of 2.6 uM).
-
DescriptionPLpro inhibitor is a potent papain-like protease (PLpro) inhibitor(IC50 of 2.6 uM)
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorpapain-like protease (PLpro)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1093070-14-4
-
Formula Weight346.42
-
Molecular FormulaC22H22N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 40 mg/mL (115.47 mM)
-
SMILESC[C@@H](NC(=O)c1cc(NC(C)=O)ccc1C)c1cccc2ccccc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ratia, K., et al., A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci U S A, 2008. 105(42): p. 16119-24.
molnova catalog
related products
-
VK-II-36
VK-II-36, a carvedilol analog, suppresses sarcoplasmic reticulum (SR) Ca(2+) release but does not block the β-receptor.
-
Linzagolix
Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.
-
22'-Cyclouridine
22'-Cyclouridine is a research tool for antiviral and anticancer studies.